Similarly, paclitaxel and curcumin in corroborating their apoptotic effect decreased breast carcinogenesis by downregulating the expressions of Rho-A, p53, c-Ha-Ras and Bcl-2 in basal-like MDA-MB-231 human breast cancer cells [57] (Table 2). Here, BCL2 is linked to breast carcinoma.